Adjuvance Technologies
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $20M
Investors
- 1
About Adjuvance Technologies
Adjuvance Technologies Inc.Founded in 2009 and headquartered in Lincoln, US, Adjuvance Technologies Inc. focuses on delivering advanced technological solutions. The company has undergone strategic developments but there are no records of significant pivots or mergers. The founders, David Gin and Jeffrey Gardner, have contributed their expertise to the growth of the firm, which has secured a total of two deals.Adjuvance Technologies Inc. offers innovative solutions designed to meet the needs of clients across sectors, particularly focusing on operational efficiency in technology, healthcare, and finance. Their flagship products utilize advanced algorithms and data analytics for informed decision-making. Services cater to a diverse client base, including SMEs and large corporations, addressing challenges such as resource management and customer engagement.The company generates revenue through a structured transaction model primarily featuring subscription-based services and direct partnerships with clients. Clients engage with Adjuvance on a contractual basis to access specific services, ensuring predictable revenue streams.Adjuvance Technologies Inc.00 mn to develop new products and expand into new markets. The company aims to launch its upcoming product line by mid-2021, targeting expansion into emerging markets in Asia and Europe by the end of 2022.
Who invested in Adjuvance Technologies
1 investor across 1 round
See all investors in Adjuvance Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 29, 2020
Amount
$20M
Investors
Questions about Adjuvance Technologies
Who invested in Adjuvance Technologies?
Adjuvance Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adjuvance Technologies raised?
Adjuvance Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Adjuvance Technologies last raise money?
Adjuvance Technologies's most recent round on record is a Series A, in Jan 2020.
What does Adjuvance Technologies do?
Adjuvance Technologies is a biotechnology company.
Where is Adjuvance Technologies headquartered?
Adjuvance Technologies is headquartered in Lincoln, US.
Which VCs invest in companies like Adjuvance Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Adjuvance Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Adjuvance Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.